Portfolio, Arpil 1, 2014

S&P 500:                 1885 (134.2%)

Portfolio:         $778,100 (155.6%)

IBB                    1153 shares    $278,622

VHT                2025 shares    $218,214

PGJ                   7750 shares    $240,560

Cash                                           $40,704

Notes: The portfolio has not made any changes this month.  China (PGJ) and biotech (IBB) holdings suffered in market that is becoming skittish, losing some of this year’s gains:

apr14

Portfolio, March 4, 2014

S&P 500:                 1874 (133.4%)

Portfolio:         $833,223 (166.6%)

IBB                    1153 shares    $310,041

VHT                2025 shares    $223,659

PGJ                   7750 shares    $259,005

Cash                                           $40,704

Notes: The portfolio has not made any changes this month, and has outperformed the S&P 500 by approximately double since beginning this blog.  The S&P 500 strongly recovered from a minor correction in February, but the portfolio was positioned in three of the best-performing sectors of February and outperformed the S&P 500:

mar14

A More Diversified Portfiolio

The model portfolio tracked in this blog is quite aggressive, seeking to hold 3-5 sector funds that give the portfolio the best chance for growth in coming months.  Although the holdings in the model portfolio are desirably not strongly correlated with one another, they lack the diversity of a traditional portfolio.  A monthly chart plotting movement of the model portfolio relative to the S&P 500 is therefore also typically provided, graphically illustrating efforts to keep the portfolio’s volatility reasonable relative to the S&P 500.

Although model portfolio volatility has been modest over the past several years given the increased performance realized, many investors have a longer time horizon for investment, and seek more diversified investments that can be held for longer periods (such as a year) between portfolio reviews.  A diversified portfolio (not including bonds, which may constitute up to 30% of such a portfolio for retirees or those wishing to further minimize volatility) is therefore provided here as a reference, such that it can be reviewed and compared against this blog’s more aggressive model portfolio.

The diversified portfolio (Feb 1, 2014) includes:

Ticker             Value             Shares
ARTJX          $100,000      3776.4          Artisan International Small Cap
DODGX        $300,000      1836.9         Dodge and Cox Stock
OAKIX          $200,000      7874.0         Oakmark International
PRSVX          $200,000      4133.9         T Rowe Price Small Cal Value
VASVX          $200,000      7352.9         Vanguard Select Value

Although the fund appears on its face that it may be biased toward international (30%) and value (40%) stocks, use of a portfolio analyzer tool such as Morningstar’s professional portfolio manager indicates the this combination of funds is 57% large cap, 24% mid-cap, and 18% small-cap, with 33% value, 36% core, and 32% growth stocks.  The diversified fund is 62% North American and 22% European, with only 2.25% in riskier Asia emerging markets and .5% in Latin America.  There is nearly no stock overlap between funds, with DODGX and VASVX both holding Capital One Financial (COF) at 1.6% total the only significant duplicate.

A diversified fund such as this is suitable for most passive investors with a long-term time horizon, and can be supplemented with a bond fund (such as PTTAX – Pimco Total Return) in an amount up to 25% or so for those wishing to further reduce volatility (note that increasing bonds beyond about 30% or so in such a portfolio has been shown to reduce portfolio returns without meaningful reduction in volatility).

Portfolio, February 7, 2014

S&P 500:                 1789 (127.3%)

Portfolio:         $757,509 (151.5%)

IBB                 1153 shares    $281,435

VHT                2025 shares    $208,312

PGJ                 7750 shares    $226,920

Cash                                           $40,704

Notes: The portfolio sold IAI, the brokerage ETF, and bought VHT, the Vanguard Health Care ETF.  Although the market in general was down for the year through February 7, the portfolio of growth sector mutual funds did not suffer the same fate:

2-7-14

Portfolio, January 10, 2014 (featuring a trade!)

S&P 500:                 1842 (131.1%)

Portfolio:         $771,287 (154.3%)

IBB                    1153 shares    $274,356

FSAVX             sold

IAI                     5675 shares     $219,004

PGJ                   7750 shares    $237,522

Cash                                            $40,405

Notes: The portfolio has made its first trade in months, as FSAVX has not performed as well as top funds/ETFs in recent months.  The portfolio has done well even since the January 2 update, in large part due to its biotech stake.

 

Stocks? Pt. 4

Through the last year, the S&P 500 is up from 1462 to 1832 (25.3%), while the Morningstar value portfolio is up 21.2%.

Of the stocks in the original portfolio, Facebook nearly doubled (99%), Amazon was up by 55%, and Applied Materials was up 50%.  Other significant gainers included Microsoft, John Wiley General Dynamics, Amgen, and Bank of New York.   Unfortunately, Potash lost 21%, and Weight Watchers lost 40% over the same period.

The portfolio as a whole slightly underperformed the S&P 500 in a relative bull market, suggesting that blindly purchasing a portfolio of stocks meeting Morningstar’s value criteria may not be an optimal investment strategy, at least in the bull market of the past year.

Portfolio, January 1, 2014

S&P 500:                 1832 (130.36%)

Portfolio:         $751,762 (150.3%)

IBB                    1153 shares    $261,823

FSAVX             3820 shares    $212,850

PGJ                   7750 shares    $236,607

Cash                                           $40,480

Notes: The portfolio has not made any changes since the October 1 update, and has outperformed the S&P 500 by 66% since beginning this blog.  The portfolio lagged the S&P 500 in October, but outperformed in November and December, as reflected in the chart below:

chart114

Portfolio, October 1, 2013

S&P 500:                 1695 (120.6%)

Portfolio:  $722,613,601 (144.5%)

IBB                   1153 shares    $246,488

FSAVX              3820 shares    $208,648

PGJ                   7750 shares    $226,997

Cash                                          $40,480

Notes: The portfolio still holds IBB (Biotech), but now holds PGJ (China) and FSAVX (autos).

oct13

Trades

The portfolio sold its position in IYZ (Telecom) on Monday, July 8, and bought the Fidelity Autos mutual fund FSAVX (the CARZ ETF is unavailable through my broker).  Positions now include:

FSAVX   3810.4  shares  $189,300

MJFOX  12141.5 shares   $185,522

IBB          1253.0 shares    $228,885

Cash:                                    $20,868

Portfolio, July 1, 2013

S&P 500:         1615 (114.9%)

Portfolio: $609,601 (121.9%)

IBB                   1253 shares    $223,647

IYZ                   7150 shares    $184,541

MJFOX     12,145.5 shares    $180,544

Cash                                          $20,868

Notes: The portfolio still holds IBB (Biotech), but sold IYT (Transportation) and ITB (Home Construction) for IYZ (Telecom) and MJFOX (Japan) at the beginning of May.  None of the four funds are up over the past two months, but we were fortunate to move out of ITB (Home Construction) before its 12% two-month decline.

June 3 numbers were as follows:

S&P 500:         1640 (116.7%)

Portfolio: $606,815 (121.3%)

IBB                   1253 shares    $222,319

IYZ                   7150 shares    $187,401

MJFOX     12,145.5 shares    $175,930

Cash                                          $20,868

jul13